Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. The American Heart ...

The heart is a muscle like no other, beating 60 to 100 times per minute on average, around the clock. But when it grows weak, it can lead to serious problems: from debilitating shortness of breath and ...

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

It is a common perception that approximately 50% of heart failure (HF) patients present with a normal or near-normal left ventricular (LV) ejection fraction ("HF with preserved systolic function"), ...

The clinician should always reinforce the fact that medications will decrease the symptoms of heart failure, prevent hospitalization, improve the quality of life, and prolong survival. Conclusion ...

Incidence of cardiotoxicity after high cumulative dose of anthracyclines in adult patients with advanced soft tissue sarcomas: A systematic review and meta-analysis. Arterial stiffness and aortic ...

A new physiological measurement of heart function developed at UVA Health could improve survival for heart-failure patients by identifying high-risk patients who require tailored treatments, a study ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA ...

Heart damage occurs when substances or medical conditions harm heart tissue. Signs of heart damage from drugs may include chest pain, irregular heartbeat, and cough. Substances can affect the cells of ...